The WVU Heart and Vascular Institute is hosting a two-day symposium focused on exploring the benefits and long-term potential of robotic aortic valve replacement. Fans of the procedure say it represents a safe, effective alternative to TAVR and SAVR in patients with severe aortic stenosis. 

The technology, developed by New Jersey-based Integra LifeSciences, is already approved for several other specialties, including neurosurgery and orthopedic surgery. 

Calcium in the coronary arteries is a known cardiac risk factor. However, new data suggest it may actually tell us more about a person's overall health than researchers previously believed. 

Researchers warned that “aggressive procedural modifications” should not be necessary during TAVR to mitigate the risk of prosthesis-patient mismatch. This appears to be true for patients receiving both self-expanding and balloon-expandable TAVR valves.

The Association of Black Cardiologists hopes to improve widespread disparities in care through the use of patient education, free diagnostic heart screenings and other proven methods. 

SCAI President Srihari Naidu, MD, detailed some of the challenges interventional cardiologists face as reimbursements keep declining. The group has been building new partnerships with other medical societies to strengthen its influence in Washington. 

First-in-human data suggest the therapy, CTX310, could be a breakthrough for patients with lipid disorders.

Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well. 

The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns.

B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.

New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension. 

Never mind artificial general intelligence. Worry about artificial superintelligence.

The family of Jeffrey Alan Fulcher, 58, sued the Medical University of South Carolina after the father of three died six days after undergoing a minimally invasive procedure to remove part of his esophagus. The state, on behalf of the hospital, settled the case out of court.